Skip to main content
Medapp Spolka Akcyjna logo

Medapp Spolka Akcyjna — Investor Relations & Filings

Ticker · MDA ISIN · PLYLWHT00012 LEI · 259400325KF6BPQ17643 WAR Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 266 across all filing types
Latest filing 2026-04-29 Regulatory Filings
Country PL Poland
Listing WAR MDA

About Medapp Spolka Akcyjna

http://www.medapp.pl

Medapp Spolka Akcyjna is a technology company that develops software solutions for digital medicine and advanced diagnostic imaging. The company's core focus is on creating tools that support medical professionals in diagnostics, treatment planning, and conducting complex medical procedures. Its flagship product, CarnaLife Holo, is an FDA-certified technology that provides three-dimensional visualization of medical imaging data using mixed and augmented reality. This system is utilized in fields such as cardiology and oncology to enhance procedural accuracy and planning. Other key offerings include the CarnaLife System, a telemedical platform for remote patient monitoring and data analysis, and HoloComm, a tool for remote 3D demonstrations. The company's solutions are built upon a foundation of artificial intelligence, 3D imaging, and big data analytics, developed through collaboration between engineers, software developers, and medical experts.

Recent filings

Filing Released Lang Actions
Zawarcie umowy dystrybucyjnej na rynku Tajlandii - Content (PL)
Regulatory Filings Classification · 1% confidence The document is a brief corporate announcement that the Management Board of MedApp S.A. has entered into a distribution agreement for its CarnaLife Holo product in Thailand. It contains no financial statements, voting results, share transactions, or report attachments. It is a regulatory disclosure of a commercial agreement and does not fall under any specific category like M&A, financing, dividend, or insider dealing. Therefore, it is best classified under the general fallback category for regulatory announcements (RNS).
2026-04-29 Polish
Rozwiązanie umowy z Zakładem Ubezpieczeń Społecznych w związku z otwarciem postępowania restrukturyzacyjnego Spółki - Content (PL)
Legal Proceedings Report Classification · 1% confidence The document is a brief regulatory announcement (683 characters) informing investors that the company received a letter from the social insurance institution (ZUS) terminating an installment agreement due to the company’s opened restructuring proceedings, and that ZUS claims will be handled in a court-approved restructuring plan. It is not an earnings announcement, capital change, or management change, but rather an update on a significant legal process (restructuring). Therefore, it falls under the “Legal Proceedings Report” category (LTR).
2026-04-29 Polish
Postanowienie o umorzeniu postępowania upadłościowego Emitenta - Content (PL)
Legal Proceedings Report Classification · 1% confidence The document is a short regulatory announcement (under 1,000 characters) issued by Medapp S.A. regarding a court decision on bankruptcy proceedings. It references previous regulatory filings (ESPI) and provides a status update on legal/restructuring proceedings. Since it is a specific update on a legal/regulatory matter that does not fit into the other specialized categories like M&A or financial reports, it is classified as a general regulatory filing.
2026-03-20 Polish
Złożenie przez podmiot zależny wniosku o udzielenie koncesji wojskowej - Content (PL)
Regulatory Filings Classification · 1% confidence The document is a formal announcement by Medapp S.A. regarding a regulatory application for a business license (concession) for military/police technology. It explicitly references Article 17 of the MAR (Market Abuse Regulation) regarding inside information. Since it does not fit into specific categories like M&A, financial results, or share transactions, and serves as a general regulatory disclosure of a strategic business development, it falls under the RNS (Regulatory Filings) category.
2026-03-03 Polish
Zawarcie umowy dystrybucyjnej na rynkach GCC - Content (PL)
Regulatory Filings Classification · 1% confidence The document is a formal announcement by MedApp S.A. regarding the signing of a distribution agreement for their CarnaLife Holo system in the GCC region. It is classified as a regulatory filing (RNS) because it is a corporate disclosure of a significant business development (a material contract) that does not fit into specific categories like M&A, financial reports, or director dealings. It follows the standard format for regulatory announcements under the MAR (Market Abuse Regulation) framework.
2026-02-11 Polish
Wstrzymanie rozpoznania wniosku o ogłoszenie upadłości przez Sąd - Content (PL)
Legal Proceedings Report Classification · 1% confidence The document is a short regulatory announcement from Medapp S.A. regarding a court decision to suspend bankruptcy proceedings pending a restructuring application. It is a brief update on a legal/regulatory matter rather than a full legal report, and it does not fit into specific categories like M&A or financial results. Therefore, it is classified as a general regulatory filing.
2026-01-28 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.